The Lancet Respiratory Medicine : Impact Factor & More
eISSN: 2213-2619pISSN: 2213-2600
Share this on:
Key Metrics
CiteScore 
61.6
Scite Index
0.86 5-Year SI
SNIP
14.7
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on The Lancet Respiratory Medicine
The Lancet Respiratory Medicine Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER SCI LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in The Lancet Respiratory Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in The Lancet Respiratory Medicine
Rethinking bronchiectasis through a metabolic lens.
- 19 May 2026
- The Lancet. Respiratory medicine
Effects of inflammatory phenotypes in acute respiratory distress syndrome on mortality and partitioning of lung and chest wall mechanics in patients in the USA and Canada: a retrospective cohort study.
- 19 May 2026
- The Lancet. Respiratory medicine
Biology meets physiology in ARDS precision medicine.
- 19 May 2026
- The Lancet. Respiratory medicine
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.
- 19 May 2026
- The Lancet. Respiratory medicine
Is the SUNRISE study a new dawn in steroid stewardship?
- 18 May 2026
- The Lancet. Respiratory medicine
Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trial.
- 18 May 2026
- The Lancet. Respiratory medicine
Rethinking bronchiectasis through a metabolic lens.
- 19 May 2026
- The Lancet. Respiratory medicine
Effects of inflammatory phenotypes in acute respiratory distress syndrome on mortality and partitioning of lung and chest wall mechanics in patients in the USA and Canada: a retrospective cohort study.
- 19 May 2026
- The Lancet. Respiratory medicine
Biology meets physiology in ARDS precision medicine.
- 19 May 2026
- The Lancet. Respiratory medicine
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.
- 19 May 2026
- The Lancet. Respiratory medicine
Is the SUNRISE study a new dawn in steroid stewardship?
- 18 May 2026
- The Lancet. Respiratory medicine
Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma (SUNRISE): a multicentre, placebo-controlled, double-blind, phase 3 trial.
- 18 May 2026
- The Lancet. Respiratory medicine
FAQs on The Lancet Respiratory Medicine
How long has The Lancet Respiratory Medicine been actively publishing? 
What is the publishing frequency of The Lancet Respiratory Medicine?
How many articles did The Lancet Respiratory Medicine publish last year?
What is the eISSN & pISSN for The Lancet Respiratory Medicine?
What is Citescore for The Lancet Respiratory Medicine?
What is SNIP score for The Lancet Respiratory Medicine?
Who is the publisher of The Lancet Respiratory Medicine?
